1. Home
  2. LAB vs LSAK Comparison

LAB vs LSAK Comparison

Compare LAB & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • LSAK
  • Stock Information
  • Founded
  • LAB 1999
  • LSAK 1997
  • Country
  • LAB United States
  • LSAK South Africa
  • Employees
  • LAB N/A
  • LSAK N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • LSAK Investment Bankers/Brokers/Service
  • Sector
  • LAB Industrials
  • LSAK Finance
  • Exchange
  • LAB Nasdaq
  • LSAK Nasdaq
  • Market Cap
  • LAB 451.0M
  • LSAK 408.0M
  • IPO Year
  • LAB 2011
  • LSAK N/A
  • Fundamental
  • Price
  • LAB $1.12
  • LSAK $4.39
  • Analyst Decision
  • LAB Buy
  • LSAK
  • Analyst Count
  • LAB 2
  • LSAK 0
  • Target Price
  • LAB $2.50
  • LSAK N/A
  • AVG Volume (30 Days)
  • LAB 999.6K
  • LSAK 24.5K
  • Earning Date
  • LAB 05-06-2025
  • LSAK 05-07-2025
  • Dividend Yield
  • LAB N/A
  • LSAK N/A
  • EPS Growth
  • LAB N/A
  • LSAK N/A
  • EPS
  • LAB N/A
  • LSAK N/A
  • Revenue
  • LAB $169,687,000.00
  • LSAK $574,080,000.00
  • Revenue This Year
  • LAB N/A
  • LSAK $0.04
  • Revenue Next Year
  • LAB $12.77
  • LSAK $1.74
  • P/E Ratio
  • LAB N/A
  • LSAK N/A
  • Revenue Growth
  • LAB 33.86
  • LSAK 4.13
  • 52 Week Low
  • LAB $0.95
  • LSAK $3.39
  • 52 Week High
  • LAB $2.74
  • LSAK $5.60
  • Technical
  • Relative Strength Index (RSI)
  • LAB 47.61
  • LSAK 46.15
  • Support Level
  • LAB $0.95
  • LSAK $3.39
  • Resistance Level
  • LAB $1.21
  • LSAK $4.55
  • Average True Range (ATR)
  • LAB 0.10
  • LSAK 0.27
  • MACD
  • LAB -0.01
  • LSAK -0.02
  • Stochastic Oscillator
  • LAB 43.42
  • LSAK 73.53

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

Share on Social Networks: